Carmen Burgaleta

Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia

Alberto Álvarez‐Larrán, Francisco Cervantes, Arturo Pereira et al. · Blood · 2010 · 234 citations · Full text

Medicine, Hematology, Pharmacotherapy +12

Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera

Alberto Álvarez‐Larrán, Arturo Pereira, Francisco Cervantes et al. · Blood · 2011 · 227 citations · Full text

Medicine, Hematology, Oncology +6

Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation

Alberto Álvarez‐Larrán, Arturo Pereira, Paola Guglielmelli et al. · Haematologica · 2016 · 147 citations · Full text

Medicine, Hematology, Pharmacology +17

Essential thrombocythemia in young individuals: frequency and risk factors for vascular events and evolution to myelofibrosis in 126 patients

Alberto Álvarez‐Larrán, Francisco Cervantes, Beatríz Bellosillo et al. · Leukemia · 2007 · 127 citations

Medicine, Hematology, Pathology +11

Changes in the natural history of progressive multifocal leukoencephalopathy in HIV-negative lymphoproliferative disorders: Impact of novel therapies

Julio García‐Suárez, Dunia de Miguel, Isabel Krsnik et al. · American Journal of Hematology · 2005 · 118 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +7